Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Adults (age 18 and over):
- People who are 18 years of age or older
- People who have had Type 1 diabetes for at least 3 years
- People who have been using a continuous glucose monitor (a small sensor that tracks blood sugar levels) for at least 6 months
- People whose doctor has approved them to start using an automated insulin delivery (AID) system — a device that automatically adjusts insulin based on blood sugar readings
- People who have already chosen a specific AID system before the screening process, after being fully informed about their options
Children:
- Children aged 7 to 17 years
- Children who have had Type 1 diabetes for at least 6 months
- Children who have been using a continuous glucose monitor for at least 6 months
- Children whose doctor has approved them to start using an automated insulin delivery (AID) system
- Children who have already chosen a specific AID system before the screening process, after being fully informed about their options
Who may not be able to join:
- People who have taken diabetes medications other than insulin, steroid medications, or other drugs that affect blood sugar levels within 30 days before the study starts, or plan to do so during the study
- People who have previously used any automated insulin delivery system, whether commercially made or built from open-source technology
- People who take paracetamol (also known as acetaminophen, e.g. Panadol) every day
- People who are currently breastfeeding, pregnant, or planning to become pregnant within 4 months
- People with alcohol or drug misuse issues
- People with serious heart disease
- People with a specific type of eye complication from diabetes that makes very well-controlled blood sugar levels unsafe (confirm with trial site)
- People with any other medical or psychological condition that the trial investigator considers makes participation unsuitable
- People who, in the investigator's judgement, are unlikely to follow the key study procedures as required
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kirsten Nørgaard, MD, Prof., Steno Diabetes Center Copenhagen
Phone: 26836584
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in change from baseline to study end in sleep efficiency between the two groups.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.